Hadi Kalantar

8PUBLICATIONS
7CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 02, 2024
Betaine alleviates doxorubicin-related cardiotoxicity via suppressing oxidative stress and inflammation via the NLRP3/SIRT1 pathway.

Yasaman Hamidavi Mohammadpour, Mohammad Javad Khodayar, Layasadat Khorsandi

|May 15, 2024
Protective effects of diosmin on doxorubicin-induced testicular toxicity in rat.

Alireza Malayeri, Shahin Moradi Birgani, Zahra Basir

|Sep 19, 2022
Diosmin prophylaxis reduces gentamicin-induced kidney damage in rats.

Seyed Sajad Hossieni Geshnigani, Masoud Mahdavinia, Mojtaba Kalantar

|Nov 22, 2021
Epicatechin ameliorative effects on methotrexate-induced hepatotoxicity in mice.

Reza Azadnasab, Hadi Kalantar, Layasadat Khorsandi

|Oct 15, 2020
Protective effects of apigenin on altered lipid peroxidation, inflammation, and antioxidant factors in methotrexate-induced hepatotoxicity.

Mehdi Goudarzi, Mojtaba Kalantar, Elahe Sadeghi

|Jun 18, 2020
Alleviation of Liver Dysfunction, Oxidative Stress and Inflammation Underlies the Protective Effect of Ferulic Acid in Methotrexate-Induced Hepatotoxicity.

Mozhdeh Roghani, Heibatullah Kalantari, Mohammad Javad Khodayar

Pageof 2